Incyte (INCY): aksiya narxi va yangiliklar

INCY:NASDAQ

Incyte

120,56 US$

+1,84%

(+2,18) 1K

120,00 US$

-0,46% (-0,56)

Yopilgandan keyin

Savdolar yopilgan: 7-avg, 16:00:01 (GMT-4) · USD

Barcha belgilar

YBB

MAKS

	Belgi	Narxi	Oʻzgartirishlar	Dinamika (%)

INCY tikeri uchun statistika yaratilmoqda...

Ochish

118,56 US$

Yuqori

120,88 US$

Past

117,38 US$

Bozor kapitali

24,44 mlrd

Oʻrtacha hajm

1,97 mln

Hajmi

1,54 mln

P/E koeffitsiyenti

15,36

52 haftalik eng yuqori

132,60 US$

52 haftalik eng past

77,69 US$

Aksiya boʻyicha daromad

7,85 US$

Beta

0,76

Muomaladagi aksiyalar

202,70 mln

Xodimlar soni

3 ming

Ochish

118,56 US$

Yuqori

120,88 US$

Past

117,38 US$

Bozor kapitali

24,44 mlrd

Oʻrtacha hajm

1,97 mln

Hajmi

1,54 mln

P/E koeffitsiyenti

15,36

52 haftalik eng yuqori

132,60 US$

52 haftalik eng past

77,69 US$

Aksiya boʻyicha daromad

7,85 US$

Beta

0,76

Muomaladagi aksiyalar

202,70 mln

Xodimlar soni

3 ming

Aloqador aksiyalar

MDGL

Madrigal Pharmaceuticals Inc

Alnylam Pharmaceuticals, Inc.

219,20 US$

+1,43%

VRTX

Vertex Pharmaceuticals Inc

496,07 US$

+2,49%

Yangiliklar

Internetdagi manbalardan

News Corp

8 soat oldin

Incyte Corp. stock outperforms competitors on strong trading day

Business Wire

8 soat oldin

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

News Corp

1 kun oldin

Incyte Corp. stock outperforms competitors despite losses on the day

Zacks

1 kun oldin

Mirum's Q2 Earnings Lag Estimates, Revenues Beat, 2026 View Raised

Profil

Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia

Incyte haqida

CEOHervé Hoppenot

Xodimlar soni2,84 ming

Asos solingan1991

Bosh ofislarWilmington, Delaver, Amerika Qo‘shma Shtatlari

Sektor-

Veb-saytincyte.com

Analitik reytinglar

Oxirgi 3 oyda INCY aksiyalari boʻyicha reyting bergan 20 tahlilchi xulosasiga koʻra

Sotib olish

Ushlab qolish

Sotish

12 oylik prognoz

Oxirgi 3 oyda INCY uchun 12 oylik narx maqsadlarini taklif qilgan 20 Wall Street tahlilchisi xulosasiga koʻra

Eng yuqori

Joriy 120,56 US$

155,00 US$ (+28,57%)

O‘rtacha

129,94 US$ (+7,78%)

Eng past

109,00 US$ (-9,59%)

Analitik	Tavsiya	Amal	Kutilayotgan narx	Prognoz	Sana
Derek Archila Wells Fargo	Hold	Maintained	116,00 US$	-3,8%	08/06/2026
Salim Syed Mizuho Securities	Buy	Maintained	137,00 US$	+13,6%	08/03/2026
Andrew Berens Leerink Partners	Buy	Maintained	155,00 US$	+28,6%	08/03/2026
Mitchell Kapoor H.C. Wainwright	Buy	Reiterated	150,00 US$	+24,4%	08/03/2026
Jessica Fye J.P. Morgan	Hold	Reiterated	120,00 US$	-0,5%	07/30/2026
Srikripa Devarakonda Truist Financial	Hold	Reiterated	-	-	07/29/2026
Salveen Richter Goldman Sachs	Hold	Maintained	118,00 US$	-2,1%	07/29/2026
Evan Seigerman BMO Capital	Hold	Maintained	130,00 US$	+7,8%	07/29/2026
Ashwani Verma UBS	Hold	Maintained	113,00 US$	-6,3%	07/28/2026
Michael Schmidt Guggenheim	Buy	Maintained	150,00 US$	+24,4%	07/28/2026
Brian Abrahams RBC Capital	Hold	Maintained	109,00 US$	-9,6%	07/28/2026
Judah Frommer Morgan Stanley	Hold	Maintained	119,00 US$	-1,3%	07/29/2026
Tazeen Ahmad Bank of America Securities	Buy	Reiterated	140,00 US$	+16,1%	07/28/2026
Etzer Darout Barclays	Buy	Reiterated	139,00 US$	+15,3%	07/28/2026
Stephen Willey Stifel Nicolaus	Buy	Maintained	145,00 US$	+20,3%	07/28/2026
Jay Olson Oppenheimer	Buy	Maintained	120,00 US$	-0,5%	07/28/2026
Matt Phipps William Blair	Hold	Maintained	-	-	07/28/2026
Marc Frahm TD Cowen	Buy	Maintained	138,00 US$	+14,5%	07/28/2026
Allison Bratzel Piper Sandler	Buy	Maintained	110,00 US$	-8,8%	06/09/2026
Unknown Analyst Bernstein	Hold	Maintained	-	-	06/01/2026
Unknown Analyst J.P. Morgan	Hold	Maintained	105,00 US$	-12,9%	05/20/2026
Unknown Analyst Guggenheim	Buy	Maintained	130,00 US$	+7,8%	05/04/2026
Unknown Analyst Argus Research	Buy	Maintained	115,00 US$	-4,6%	04/30/2026
Faisal Khurshid Jefferies	Hold	Downgraded	94,00 US$	-22%	03/15/2026
Unknown Analyst Evercore ISI	Hold	Maintained	110,00 US$	-8,8%	03/05/2026

Barcha qiymatlar – USD	sen, 2025	dek, 2025	mar, 2026	iyn, 2026
Daromad	1,37 mlrd	1,51 mlrd	1,27 mlrd	1,67 mlrd
Sotilgan mahsulotning tannarxi	605,58 mln	732,55 mln	620,43 mln	621,91 mln
Daromad narxi	605,58 mln	732,55 mln	620,43 mln	621,91 mln
Tadqiqot va ishlanmalarga xarajatlar	-	-	-	-
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar	-	-	-	-
Tijoriy, umumiy va maʼmuriy xarajatlar	328,29 mln	388,96 mln	327,06 mln	350,72 mln
Operatsion xarajatlar	328,29 mln	388,96 mln	327,06 mln	350,72 mln
Jami operatsion xarajatlar	933,87 mln	1,12 mlrd	947,49 mln	972,63 mln
Operatsion daromad	432,11 mln	385,32 mln	325,19 mln	701,41 mln
Boshqa nooperatsion daromad	3,25 mln	4,22 mln	1,75 mln	5,26 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar	482,31 mln	389,94 mln	343,60 mln	751,51 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno	461,55 mln	419,71 mln	360,06 mln	744,21 mln
Daromad soligʻi boʻyicha xarajat	58,14 mln	90,66 mln	40,27 mln	165,91 mln
Amaldagi soliq stavkasi	12,05%	23,25%	11,72%	22,08%
Boshqa operatsion xarajatlar	-	-	-	-
Sof foyda	424,17 mln	299,28 mln	303,33 mln	585,60 mln
Sof foyda marjasi	31,05%	19,86%	23,83%	34,98%
Har bir aksiya foydasi	2,26	1,80	1,81	3,09
Foizlar va investitsiyalardan olingan daromadlar	26,78 mln	30,75 mln	33,69 mln	38,12 mln
Foizlarni toʻlash xarajatlari	-592,00 ming	-582,00 ming	-569,00 ming	-582,00 ming
Foizlarni toʻlash boʻyicha sof xarajatlar	26,19 mln	30,17 mln	33,12 mln	37,54 mln
Amortizatsiya ajratmalari	-	-	-	-
EBITDA	456,13 mln	409,30 mln	348,99 mln	727,89 mln
Aktivlarni sotishdan olingan foyda yoki zarar	-	-	-	-

AI kontentda xatolar boʻlishi mumkin. Batafsil

YordamFikr-mulohazaMaxfiylik Shartlar Majburiyatlardan voz kechish

Finance

Tahlil